Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

ADMSC-derived exosomes promote diabetic wound healing by inhibiting neutrophil extracellular traps formation through delivering miR-92a-1-5p.

Li W., Zhang H., Bai P., Wang H., Hou F., Zhou Z.

Animal Study on Diabetic Foot, Chronic Wound, published in Arch Biochem Biophys (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Arch Biochem Biophys (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41628774
DOI
10.1016/j.abb.2026.110755

Abstract (original English)

Adipose-derived mesenchymal stem cell-derived exosomes (ADMSC-ex) have demonstrated remarkable efficacy in promoting diabetic wound healing. However, the underlying mechanisms remain largely elusive. In this study, we showed the healing process of skin wounds in diabetic rats was notably delayed, but this delay was mitigated by the administration of ADMSCs-ex. Neutrophil extracellular traps (NETs) formation was significantly upregulated in the skin wounds from the diabetes group. ADMSCs-ex administration attenuated this upregulation. The upregulation of S100A9 was confirmed in wound tissues from diabetic rats, as well as neutrophils induced by high glucose. ADMSCs-ex administration significantly reduced S100A9 protein expression via delivering miR-92a-1-5p in vitro. In vivo study showed that miR-92a-1-5p knockdown obstructed the promotional effect of ADMSCs-ex on diabetic wound healing and NETs formation. In conclusion, this study provides evidence that ADMSCs-ex accelerate diabetic wounds healing via a conserved miR-92a-1-5p/S100A9 pathway. These findings suggest that these exosomes loaded with miR-92a-1-5p may represent a promising therapeutic approach for the management of impaired healing of diabetic wounds.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ExosomesWound HealingDiabetes ComplicationsMesenchymal Stem CellsAdipose TissueExtracellular TrapsNeutrophilsMicroRNAsMaleAnimals

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research